Completed PHASE4 INTERVENTIONAL 1-arm NCT04123652

Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain

Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain: an Observational Prospective Study

Sponsor: Allevio Pain Management Clinic

Conditions Chronic Neuropathic Pain and Fibromyalgia

Interventions Lidocaine Hydrochloride 2% Intravenous Solution, DIN 02421992

Updated 4 times since 2019 Last updated: Dec 3, 2020 Started: Nov 5, 2017 Primary completion: Nov 11, 2020 Completion: Nov 11, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04123652, this PHASE4 trial focuses on Chronic Neuropathic Pain and Fibromyalgia and remains completed. Sponsored by Allevio Pain Management Clinic, it has been updated 4 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Nov 2019 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allevio Pain Management Clinic

Data source: Allevio Pain Management Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada